Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nishida

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
The American Journal of Physiology|November 1, 1995
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppressionA Nishida, A Kobayashi-Uchida, S Akuzawa, et al.
Biochemistry|September 19, 2001
Structural requirements of sphingosine molecules for inhibition of DNA primase: biochemical and computational analysesY Ito, K Tamiya-Koizumi, Y Koide, et al.
Psychiatry and Clinical Neurosciences|July 29, 1998
Positive influence of a liaison program on the rate of psychiatric consultation referrals for cancer patientsY Uchitomi, T Akechi, H Okamura, et al.
Arzneimittel-Forschung|June 3, 1998
Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistulaY Takemoto, H Yuki, A Nishida, et al.
Acta Psychiatrica Scandinavica|July 21, 2009
Psychotic-like experiences are associated with suicidal feelings and deliberate self-harm behaviors in adolescents aged 12-15 yearsA Nishida, T Sasaki, Y Nishimura, et al.
Journal of Medicinal Chemistry|January 31, 1997
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonistG Semple, H Ryder, D P Rooker, et al.
Clinical and Translational Gastroenterology|June 27, 2014
Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndromeP Marquis, K E Lasch, L Delgado-Herrera, et al.
Vox Sanguinis|August 21, 2008
Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofiltersM Yunoki, S Yamamoto, H Tanaka, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 31, 2012
Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancyH Araoka, T Fujii, K Izutsu, et al.
Bone Marrow Transplantation|July 4, 2012
Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxisM Ogata, T Satou, Y Inoue, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
The American Journal of Physiology|November 1, 1995
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppressionA Nishida, A Kobayashi-Uchida, S Akuzawa, et al.
Biochemistry|September 19, 2001
Structural requirements of sphingosine molecules for inhibition of DNA primase: biochemical and computational analysesY Ito, K Tamiya-Koizumi, Y Koide, et al.
Psychiatry and Clinical Neurosciences|July 29, 1998
Positive influence of a liaison program on the rate of psychiatric consultation referrals for cancer patientsY Uchitomi, T Akechi, H Okamura, et al.
Arzneimittel-Forschung|June 3, 1998
Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistulaY Takemoto, H Yuki, A Nishida, et al.
Acta Psychiatrica Scandinavica|July 21, 2009
Psychotic-like experiences are associated with suicidal feelings and deliberate self-harm behaviors in adolescents aged 12-15 yearsA Nishida, T Sasaki, Y Nishimura, et al.
Journal of Medicinal Chemistry|January 31, 1997
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonistG Semple, H Ryder, D P Rooker, et al.
Clinical and Translational Gastroenterology|June 27, 2014
Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndromeP Marquis, K E Lasch, L Delgado-Herrera, et al.
Vox Sanguinis|August 21, 2008
Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofiltersM Yunoki, S Yamamoto, H Tanaka, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 31, 2012
Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancyH Araoka, T Fujii, K Izutsu, et al.
Bone Marrow Transplantation|July 4, 2012
Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxisM Ogata, T Satou, Y Inoue, et al.
Pageof 20